Clinical Trial Update: Study of Artery Conditions of 'At-risk' Asian People Not on Lipid-lowering Drugs [NA]

View source ↗

Summary

Clinical trial completion update for a study evaluating artery conditions in at-risk Asian individuals not on lipid-lowering drugs, sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: AstraZeneca | Conditions: Cardiovascular Disease | NA | Status: COMPLETED